文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

停用口服氯己定并实施口腔护理集束对ICU机械通气患者死亡率的影响(CHORAL):多中心阶梯楔形整群随机对照试验

Effect of oral chlorhexidine de-adoption and implementation of an oral care bundle on mortality for mechanically ventilated patients in the intensive care unit (CHORAL): a multi-center stepped wedge cluster-randomized controlled trial.
PubMed 文献 · Intensive Care Med · 2021-10-05
一句话结论在机械通气ICU患者中,停用氯己定并实施口腔护理集束未降低ICU死亡率,但可能改善口腔健康。

CHORAL试验在加拿大6个ICU开展阶梯楔形整群随机对照,纳入3260例机械通气患者(对照1560例,干预1700例)。干预为停用口服氯己定并实施标准化口腔护理集束。主要终点ICU死亡率干预组23.5% vs 对照组21.2%(aOR 1.13,95%CI 0.82–1.54,P=0.46),无显著差异。IVAC时间、拔管时间(存活者)、口腔操作疼痛均无差异,但口腔健康功能障碍评分改善(-0.96,95%CI -1.75至-0.17,P=0.02)。

要点

  • 停用氯己定+口腔护理集束未降低ICU死亡率:23.5% vs 21.2%,aOR 1.13(95%CI 0.82–1.54,P=0.46)。
  • IVAC时间无差异:aHR 1.06(95%CI 0.44–2.57,P=0.90)。
  • 存活者拔管时间无差异:aHR 1.03(95%CI 0.85–1.23,P=0.79)。
  • 口腔操作疼痛无显著差异:aOR 0.62(95%CI 0.34–1.10,P=0.10)。
  • 口腔健康功能障碍评分改善:-0.96(95%CI -1.75至-0.17,P=0.02)。

适用人群与场景

  • 6个加拿大ICU的机械通气患者,共3260例(对照1560例,干预1700例)。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 干预措施:停用口服氯己定并实施标准化口腔护理集束。
  • 原文未提及口腔护理集束的具体组成、药物剂量、频次或目标值。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:多中心阶梯楔形整群随机对照试验,6个ICU,样本量3260例(对照1560例,干预1700例)。
  • 主要终点ICU死亡率:干预组23.5% vs 对照组21.2%,aOR 1.13(95%CI 0.82–1.54,P=0.46)。
  • 次要终点:IVAC时间aHR 1.06(95%CI 0.44–2.57,P=0.90);存活者拔管时间aHR 1.03(95%CI 0.85–1.23,P=0.79);口腔操作疼痛aOR 0.62(95%CI 0.34–1.10,P=0.10);口腔健康功能障碍评分-0.96(95%CI -1.75至-0.17,P=0.02)。

证据类型、等级与局限

  • 证据类型:多中心阶梯楔形整群随机对照试验。
  • 局限:原文未明确列出局限;设计上为整群随机、开放标签(原文未提及盲法),样本来自6个加拿大ICU。

对床旁实践的改变

  • 对于机械通气ICU患者,停用氯己定并实施口腔护理集束不应以降低ICU死亡率为目标。
  • 该干预可能改善口腔健康,但需结合原文未提及的具体集束组成和适用人群。

指南或共识出处

  • CHORAL trial, Intensive Care Med.

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

PURPOSE: Oral chlorhexidine is used widely for mechanically ventilated patients to prevent pneumonia, but recent studies show an association with excess mortality. We examined whether de-adoption of chlorhexidine and parallel implementation of a standardized oral care bundle reduces intensive care unit (ICU) mortality in mechanically ventilated patients.

METHODS: A stepped wedge cluster-randomized controlled trial with concurrent process evaluation in 6 ICUs in Toronto, Canada. Clusters were randomized to de-adopt chlorhexidine and implement a standardized oral care bundle at 2-month intervals. The primary outcome was ICU mortality. Secondary outcomes were time to infection-related ventilator-associated complications (IVACs), oral procedural pain and oral health dysfunction. An exploratory post hoc analysis examined time to extubation in survivors.

RESULTS: A total of 3260 patients were enrolled; 1560 control, 1700 intervention. ICU mortality for the intervention and control periods were 399 (23.5%) and 330 (21.2%), respectively (adjusted odds ratio [aOR], 1.13; 95% confidence interval [CI] 0.82 to 1.54; P = 0.46). Time to IVACs (adjusted hazard ratio [aHR], 1.06; 95% CI 0.44 to 2.57; P = 0.90), time to extubation (aHR 1.03; 95% CI 0.85 to 1.23; P = 0.79) (survivors) and oral procedural pain (aOR, 0.62; 95% CI 0.34 to 1.10; P = 0.10) were similar between control and intervention periods. However, oral health dysfunction scores (- 0.96; 95% CI - 1.75 to - 0.17; P = 0.02) improved in the intervention period.

CONCLUSION: Among mechanically ventilated ICU patients, no benefit was observed for de-adoption of chlorhexidine and implementation of an oral care bundle on ICU mortality, IVACs, oral procedural pain, or time to extubation. The intervention may improve oral health.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Dale CM, Rose L, Carbone S, et al. Effect of oral chlorhexidine de-adoption and implementation of an oral care bundle on mortality for mechanically ventilated patients in the intensive care unit (CHORAL): a multi-center stepped wedge cluster-randomized controlled trial. Intensive Care Med. 2021. PMID: 34609548. doi:10.1007/s00134-021-06475-2

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。